The Southern Italian Children, Adolescents and PaRents COhort Study on Nutrition and Health
NCT ID: NCT05784376
Last Updated: 2023-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1500 participants
OBSERVATIONAL
2023-07-01
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CHOKing Prevention Project
NCT03218618
Joint School-Health Project of the Neapolitan Child
NCT05901220
Discordance of Obesity in Adolescent Sibilngs
NCT02376439
Paediatric Obesity and Cardiovascular Dysfunction
NCT03169257
Childhood Obesity: a Study of Group Treatment Targeting Parents Behaviour
NCT00842777
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The ICARO study consists of two parts, namely Study 1 (observational) and Study 2 (intervention Study).
The main objectives of the ICARO Study (Study 1) are to:
1. Evaluate the diet of participants (i.e. children, adolescents and their parents/caregivers) in terms of food composition (i.e. calorie, macro- and micronutrient contents) and complemented by a timely and innovative approach based on the evaluation of food processing, in line with the notion that the nutrient balance of a food is only a small part of its overall health potential (10);
2. Investigate major demographic, socioeconomic, behavioural, psychosocial, and other environmental factors as potential correlates of diet and diet-related habits of both children, adolescents and parents;
3. Analyse parental influence (e.g. food attitudes and knowledge) on children and adolescents diet quality and eating habits.
Within the ICARO Study population, an Intervention Study (Study 2) is planned to increase awareness and promote adherence to a minimally-processed Mediterranean Diet and reduce the dietary share of UPFs at family level.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Education-based
Nutrition education delivered via text messages through mobile applications (e.g. WhatsApp).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* refusal to sign informed consent;
* lack of an electronic device with internet access (i.e. computer, mobile phone).
2 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universita degli Studi di Catania
OTHER
Neuromed IRCCS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marialaura Bonaccio
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marialaura Bonaccio, PhD
Role: PRINCIPAL_INVESTIGATOR
IRCCS Istituto Neurologico Mediterraneo Neuromed
Licia Iacoviello, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
IRCCS Istituto Neurologico Mediterraneo Neuromed
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DEP_012023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.